EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Adjusting for medication status in genome-wide association studies

Amanda H W Chong iD, Christopher Kintu, Yoonsu Cho, Segun Fatumo, Jason Torres iD, George Davey Smith iD, Tom R Gaunt, Gibran Hemani iD

PLOS Genetics · 02.11.2026 · 22 (11) · e1012366

DOI: 10.1371/journal.pgen.1012366 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Genetics, online erschienen am 02.11.2026. Verfasst von Amanda H W Chong und 7 weiteren Autor:innen. Beteiligte Einrichtung: MRC Integrative Epidemiology Unit, Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom. Hauptthemen laut MEDLINE: Genome-Wide Association Study. Die Arbeit nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

When conducting genome-wide association studies, addressing medication status that is relevant to the trait of interest can prevent biases that could distort estimates of the true genetic effect. Here, we introduce the genetic empirical medication reduction adjustment (GEMRA) method which uses a heuristic search for an empirical adjustment to be applied to phenotypic values of participants reporting medication use. Through simulations we show that the direct genetic effect estimates in the GEMRA approach exhibited less bias and greater statistical power than common strategies such as including medication as a covariate, restricting the sample to unmedicated users or including all samples without adjustment. We then applied the GEMRA approach to estimate statin medication adjustment for analysis of low-density lipoprotein (LDL) cholesterol levels and antihypertensive medication adjustment for analyses of systolic (SBP) and diastolic (DBP) blood pressure using multi-population data from UK Biobank and the Uganda Genome Resource. We found that a relative rather than an absolute adjustment better modelled the effect of medication on LDL cholesterol, SBP and DBP, with an effect of 40%, 10% and 10% reduction appearing to be consistent across populations, respectively. We also show that spurious differences in medication effects across populations can arise when the effect scale is misspecified.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Genome-Wide Association StudyHumansCholesterol, LDLBlood PressureHydroxymethylglutaryl-CoA Reductase InhibitorsPhenotypeAntihypertensive AgentsPolymorphism, Single Nucleotide

Substanzen

Cholesterol, LDLHydroxymethylglutaryl-CoA Reductase InhibitorsAntihypertensive Agents

Autor:innen und Institutionen

  • MRC Integrative Epidemiology Unit, Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom.
  • MRC/UVRI and LSHTM Uganda Research Unit, Entebbe, Uganda.
  • The Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, United Kingdom.
  • Medical Research Council Population Health Research Unit, Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom.
  • NIHR Bristol Biomedical Research Centre, University Hospitals Bristol and Weston NHS Foundation Trust and University of Bristol, Bristol, United Kingdom.

ORCID-Profile: Amanda H W Chong, Jason Torres, George Davey Smith, Gibran Hemani

Zitieren

APA

Chong, A. H. W., Kintu, C., Cho, Y., Fatumo, S., Torres, J., Davey Smith, G., Gaunt, T. R., & Hemani, G. (2026). Adjusting for medication status in genome-wide association studies. PLOS Genetics, 22(11), e1012366. https://doi.org/10.1371/journal.pgen.1012366

Vancouver

Chong AHW, Kintu C, Cho Y, Fatumo S, Torres J, Davey Smith G, et al. Adjusting for medication status in genome-wide association studies. PLOS Genetics. 2026;22(11):e1012366. doi:10.1371/journal.pgen.1012366

BibTeX
@article{Chong2026,
  author = {Chong, Amanda H W and Kintu, Christopher and Cho, Yoonsu and Fatumo, Segun and Torres, Jason and Davey Smith, George and Gaunt, Tom R and Hemani, Gibran},
  title = {Adjusting for medication status in genome-wide association studies},
  journal = {PLOS Genetics},
  year = {2026},
  volume = {22},
  number = {11},
  pages = {e1012366},
  doi = {10.1371/journal.pgen.1012366}
}
Kostenlos starten →